Last updated on April 16, 2014 at 17:34 EDT

Local Government Announces Cost and Safety Benefits of First i.v.STATION Robot at University Hospital in African Continent

May 8, 2013

BOZEN, Sud-Tirol, Italy, May 8, 2013 /PRNewswire/ –

Health Robotics’ i.v.STATION Robot continued on its undeterred path to collect
endorsements and customer testimonials from pharmacists all over the world, documenting
its unprecedented cost savings and patient safety benefits.

The Government of Canary Islands’ Health Counsel stated in its official press release
last week: “With the implementation of the i.v.STATION Robot, the Pharmacy Department at
University Hospital of Gran Canaria Doctor Negrin assures the correct preparation of
injectable medications for patient administration with the maximum guarantees of safety,
by minimizing dose errors, cross contamination, and hospital-acquired infections, while
protecting clinical staff. In addition, the i.v.STATION Robot saves costs and reduces
turnaround time, benefiting the patients while optimizing pharmacy staffing levels.”


Gaspar DeViedma, Health Robotics’ Executive Vice President and Board Member, stated:
“Health Robotics’ first installation in the African continent is yet another example that
the i.v.STATION Robot has gone mainstream with consistent cost savings and safety benefits
for global hospitals. Reaching 175 Robot installations and an overwhelming 90% market
share, Health Robotics now has approximately 10 times more Robot installations than all of
its worldwide competitors[1] combined
http://www.health-robotics.com/en/compare-products, in North America, Europe, Asia,
South America, Australia, and now also in Africa.”

The Government of Canary Islands Health Counsel continued: “The i.v.STATION Robot
prepares liquid and powder medications in syringes and IV Bags for biologic, antifungal,
intravitreous, and antibiotic drugs, which where formerly prepared in laminar airflow
hoods in the Pharmacy, or the case of antibiotics at some of the wards or nurse stations
throughout the hospital. The i.v.STATION Robot security features include the automatic
verification of each ingredient’s weight, the automatic bar-code labeling of final
containers, and complete audit trail of the compounding process. This improves the
guarantees on sterility, conservation, and extended expiration date, due to i.v.STATION’s
air quality and ultraviolet sterilization chamber. Finally i.v.STATION has the extra cost
saving benefits of re-using vials, which optimizes the cost of expensive drugs, and the
reduced labor costs associated with clinical staff injuries due to needle-stick and
repetitive strain.”

About Health Robotics:

Founded in 2006 and now reaching 80% total IV Robots market share in the world
[including over 90% the Oncology Robots global market], Health Robotics is the undisputed
leading supplier of life-critical intravenous medication robots, providing over 350
hospital installations in 6 continents with the only fully-integrated robotics-based
technology, IV Workflow, and manual compounding software automation solution. Health
Robotics’ second generation products [i.v.STATION, i.v.SOFT, and i.v.STATION ONCO] have
been found [through scientific and peer-reviewed studies[2],[3]] to greatly contribute to
ease hospitals’ growing pressures to improve patient safety[2], increase throughput, and
contain costs[2]. Through the effective and efficient production of sterile, accurate,
tamper-evident and ready-to-administer IVs, Health Robotics’ medical devices and
integrated workflow solutions help hospitals eliminate life-threatening drug[2] and
diluent[2] exchange errors, improve drug potency[3], decrease other medical mistakes and
sterility risks, work more efficiently[2], reduce waste and controlled substances’
diversion, and diminish the gap between rising patient volume/acuity and scarce nursing,
and pharmacy staff. For more information, please visit: http://www.health-robotics.com


1. Ten Global Competitors: Intelligent Hospital Systems/RIVA, Fresenius Kabi/MDS,
Baxter/Baxa, Loccioni, Kiro, Panasonic, Yuyama, Yasukawa, Integra, and Pharmaduct

2. Impact of Robotic Antineoplastic Preparation on Safety, Workflow, Costs. Seger,
Churchill, Keohane, Belisle, Wong, Sylvester, Chesnick, Burdick, Wien, Cotugno, Bates, and
Rothschild. Brigham & Women’s Hospital, Massachusetts College of Pharmacy, and Harvard
Medical School. Journal of Oncology Practice, Nov. 2012, Volume 8, number 6.

3. Validation of an automated method for compounding monoclonal antibody patient
doses: case studies of Avastin(R), Remicade(R), and Herceptin(R). Peters, Capelle,
Arvinte, van de Garde. St. Antonius Hospital. mAbs January 2013, Volume 5, Issue 1.

        For additional information, please contact:
        Claudia Perez
        Phone +1-786-417-1251

SOURCE Health Robotics

Source: PR Newswire